← Leaderboards
Kevin John Whaley
Johns Hopkins University
$16,227,655
Attributed
$16,351,920
Total exposure
12
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.8M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$39,060,694 · 15
By mechanism
U19$18,434,030 · 2
P50$9,079,089 · 2
R44$4,432,034 · 3
U54$3,338,470 · 2
R43$2,702,657 · 5
P01$1,074,414 · 1
Top collaborators
- Deborah J Anderson12 shared
- Thomas Ray Moench12 shared
- Michael H Pauly1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Deborah J Anderson$20,708,269
- Richard A Cone$17,702,134
- Richard J Jones$17,555,212
- Taha E Taha$127,127,060
- Edgar Raymond Miller$10,285,998
Others in their field
Top investigators on “Vagina”
- Tracey Devoir · Booz Allen Hamilton, Inc.$49,200,509
- James Ter Maat · Social And Scientific Systems, Inc.$49,025,547
- Thomas Hope · Northwestern University$29,067,774
- Alexa Fraser · National Opinion Research Center$26,867,847
- Francois J Villinger · Emory University$25,554,864
- Maria Mori Brooks · University Of Pittsburgh At Pittsburgh$23,967,448
Research focus
VaginaSafetyNicotianaMonoclonal AntibodiesBaseAntibodiesPreventFilmWomanPreventionIndustrializationPreclinical StudyPharmaceutical PreparationsClinical ResearchDoseFutureIn VitroMonoclonal AntibodyPharmacology And ToxicologyNonhuman PrimateSimplexvirusCostTechnologyMicrobicide
Grant awards (43)
Development of a monoclonal therapy for neonatal herpes$248,531
R44 · FY2025 · AI
Antibody-based Contraceptive MPTs: Preclinical and Clinical Research$1,813,579
P50 · FY2021 · HD
Industrialization of Antibody-based Contraceptive MPTs$898,613
P50 · FY2021 · HD · contact PI
Antibody-based Contraceptive MPTs: Preclinical and Clinical Research$1,867,062
P50 · FY2020 · HD
Industrialization of Antibody-based Contraceptive MPTs$1,101,179
P50 · FY2020 · HD · contact PI
Antibody-based Contraceptive MPTs: Preclinical and Clinical Research$2,042,218
P50 · FY2019 · HD
Industrialization of Antibody-based Contraceptive MPTs$1,356,438
P50 · FY2019 · HD · contact PI
Antibody-based Contraceptive MPTs: Preclinical and Clinical Research$2,000,000
U54 · FY2018 · HD
Industrialization of Antibody-based Contraceptive MPTs$1,338,470
U54 · FY2018 · HD · contact PI
An SEB Immunoprotectant$306,794
R44 · FY2016 · AI · contact PI
Monoclonal Antibody-based Multipurpose Microbicides$288,303
U19 · FY2016 · AI
Monoclonal Antibody-based Multipurpose Microbicides$2,408,349
U19 · FY2015 · AI
An SEB Immunoprotectant$1,000,000
R44 · FY2015 · AI · contact PI
Critical Path Project: Mapp66, a Multi-antibody Prevention Product$99,679
U19 · FY2015 · AI · contact PI
Monoclonal Antibody-based Multipurpose Microbicides$2,530,562
U19 · FY2014 · AI
An SEB Immunoprotectant$1,000,000
R44 · FY2014 · AI · contact PI
Critical Path Project: Mapp66, a Multi-antibody Prevention Product$103,127
U19 · FY2014 · AI · contact PI
Monoclonal Antibody-based Multipurpose Microbicides$27,182
U19 · FY2014 · AI
Monoclonal Antibody-based Multipurpose Microbicides$3,098,297
U19 · FY2013 · AI
Critical Path Project: Mapp66, a Multi-antibody Prevention Product$1,138,391
U19 · FY2013 · AI · contact PI
Monoclonal Antibody-based Multipurpose Microbicides$3,573,839
U19 · FY2012 · AI
Critical Path Project: Mapp66, a Multi-antibody Prevention Product$1,185,347
U19 · FY2012 · AI · contact PI
Monoclonal Antibody-based Multipurpose Microbicides$26,134
U19 · FY2012 · AI
Monoclonal Antibody-based Multipurpose Microbicides$3,033,249
U19 · FY2011 · AI
Critical Path Project: Mapp66, a Multi-antibody Prevention Product$921,571
U19 · FY2011 · AI · contact PI
Monoclonal Antibody SEB Immunoprotectant$299,844
R43 · FY2009 · AI · contact PI
Monoclonal Antibody SEB Immunoprotectant$299,977
R43 · FY2008 · AI · contact PI
Plantibodies and Plantibody Hybrids as HIV Microbicides$189,461
R43 · FY2003 · AI
HSV PLANTIBODIES: A MICROBICIDAL LUBRICANT$812,749
R44 · FY2002 · AI
Plantibodies and Plantibody Hybrids as HIV Microbicides$300,000
R43 · FY2002 · AI
MUCOSAL PLANTIBODIES: Anti-HIV$293,788
R43 · FY2002 · AI
ANTI-HPV HUMAN MONOCLONALS FOR A VAGINAL MICROBICIDE$293,757
R43 · FY2002 · AI
BLOCKING STD PATHOGEN ENTRY WITH MUCOSAL ANTIBODIES$180,480
P01 · FY2002 · AI
BLOCKING STD PATHOGEN ENTRY WITH MUCOSAL ANTIBODIES$180,480
P01 · FY2002 · AI
HSV PLANTIBODIES: A MICROBICIDAL LUBRICANT$734,350
R44 · FY2001 · AI
MUCOSAL PLANTIBODIES: ANTI-HIV$293,788
R43 · FY2001 · AI
ANTI-HPV HUMAN MONOCLONALS FOR A VAGINAL MICROBICIDE$248,490
R43 · FY2001 · AI
HIV PLANTIBODIES: PREVENTING INFECTION$241,775
R43 · FY2001 · AI
BLOCKING STD PATHOGEN ENTRY WITH MUCOSAL ANTIBODIES$180,480
P01 · FY2001 · AI
HSV PLANTIBODIES: A MICROBICIDAL LUBRICANT$329,610
R44 · FY2000 · AI
BLOCKING STD PATHOGEN ENTRY WITH MUCOSAL ANTIBODIES$266,487
P01 · FY2000 · AI
BLOCKING STD PATHOGEN ENTRY WITH MUCOSAL ANTIBODIES$266,487
P01 · FY2000 · AI
HIV PLANTIBODIES: PREVENTING INFECTION$241,777
R43 · FY2000 · AI